CytoSorbents Corporation (CTSO)

[Murph1953]

The Italian connection.

The paper re CAR-T came from Italy.
aurthors -Bottari, Gabriella MD1; Merli, Pietro MD2; Guzzo, Isabella MD3; Stoppa, Francesca MD1; Ruggeri, Annalisa MD, PhD2; Di Nardo, Matteo MD1; Del Bufalo, Francesca MD2; Galaverna, Federica MD, PhD2; Corrado, Cecchetti MD1; Locatelli, Franco MD, PhD2Author Information-----all from Rome

CARL'S FRIENDS

"Alberto Mantovani, professor at the Humanitas University of Milan and scientific director of the Humanitas Research Hospital, who in the 1970s was one of the first people in the world to discover the mechanisms that cancer cells activate to block the natural defences of the body; CARL JUNE, director of the Center for Cellular Immunotherapies of the University of Pennsylvania and

https://www.ibsafoundation.org/forum/revolutionary-therapies-for-cancer/

"Dr Marco Ruella obtained his medical degree with honors from the University of Torino (Turin, Italy) in 2007, and completed his specialization in clinical hematology in 2012. He worked as an attending physician at the Hematology and Cell Therapy Division of the Mauriziano Hospital (Turin, Italy) and was an instructor at the Biotechnology School at the University of Torino.

From 2012, he was a post-doctoral fellow and then instructor at the University of Pennsylvania (PA, USA) in the Center for Cellular Immunotherapies under the mentorship of DR. CARL JUNE.."

https://www.bioanalysis-zone.com/2018/12/04/car-t-cell-immunotherapy-interview-marco-ruella_spotl_cell_gene/

"Dr. Rotolo received her MD from the University of Torino in her native Italy..
..Upon completing her PhD, Dr. Rotolo became a Postdoctoral Fellow at the University of Pennsylvania in order to work with CAR T-cell pioneer CARL JUNE, MD, and her Fellowship sponsor, Marco Ruella, MD (above link).

https://lymphoma.org/researcher-spotlight-rotolo/
***********************
Maybe The CRS Father, Chan, should make Gilead and Novartis an offer they can't refuse.